Galectin Therapeutics director proposes $112K share sale

A separate June 26 transaction involved 7,732 common shares and gross proceeds of $38,680.

Accepted by SEC EDGAR 06/29/2026 - 04:09 PM EDT Learn about SEC filing dates

Rhea-AI Filing Summary

Galectin Therapeutics Inc. (GALT) director Harold Shlevin gave notice of a proposed sale of 22,268 common shares, with an approximate sale date of June 29, 2026. The shares were acquired through a stock option exercise on January 23, 2025, with cash paid upon exercise. Shlevin also reported selling 7,732 common shares on June 26, 2026, for gross proceeds of $38,680. The notice lists August 29, 2025 as the plan adoption or instruction date for Rule 10b5-1 reliance.

Key Figures

Shares to be sold: 22,268 shares Aggregate market value: $112,211.88 Shares outstanding: 65,856,898 shares +2 more

5 metrics

Shares to be sold 22,268 shares Proposed sale; approximate sale date June 29, 2026

Aggregate market value $112,211.88 Shares listed for the proposed sale

Shares outstanding 65,856,898 shares Issuer shares outstanding as reported

Shares sold 7,732 shares Sale on June 26, 2026

Gross proceeds $38,680 Sale on June 26, 2026

Key Terms

Rule 10b5-1, Aggregate Market Value, STOCK OPTION EXERCISE

3 terms

Rule 10b5-1 regulatory

"If Relying on Rule 10b5-1"

Rule 10b5-1 is a regulation that allows company insiders to buy or sell their shares at predetermined times, even if they have access to non-public information. It acts like setting a schedule in advance for transactions, helping prevent accusations of unfair trading. This rule provides a way for insiders to plan trades transparently, giving investors confidence that these transactions are not based on hidden information.

Aggregate Market Value financial

"Aggregate Market Value"

Aggregate market value is the combined price you would pay to buy all outstanding shares of a company or all companies in a group at current market prices — essentially the sum of each stock’s market capitalization. It matters to investors because it shows the overall size and weight of an investment or sector (like the total cost to buy every piece of a puzzle), helps compare scale across companies or markets, and influences index composition and risk exposure.

STOCK OPTION EXERCISE financial

"Nature of Acquisition Transaction | STOCK OPTION EXERCISE"

A stock option exercise is the act of using a previously granted right to buy shares of a company's stock at a specific, predetermined price by paying that price and receiving the shares. It matters to investors because exercising changes who owns the shares (which can dilute existing ownership), can trigger taxable events and shift potential gains or losses, and affects voting power and the company’s outstanding share count—like turning a voucher into an actual product that becomes part of circulating supply.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

How many GALT shares does Harold Shlevin plan to sell?

Shlevin's notice lists 22,268 common shares for a proposed sale, with an approximate sale date of June 29, 2026. The listed aggregate market value is $112,211.88, and Merrill Lynch is named as the broker.

How many GALT shares did Harold Shlevin sell, and for how much?

Shlevin reported selling 7,732 common shares on June 26, 2026, for gross proceeds of $38,680.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK	0001557082
Filer CCC	XXXXXXXX
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer	GALECTIN THERAPEUTICS INCORPORATED
SEC File Number
Address of Issuer	4960 Peachtree Industrial Blvd. Ste 240 Norcross GEORGIA 30071
Phone	6786203186
Name of Person for Whose Account the Securities are To Be Sold	Harold Shlevin
See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.
Relationship to Issuer	Director

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
COMMON	MERRILL LYNCH 401 E. LAS OLAS BLVD 9TH FL FORT LAUDERDALE FL 33301	22268	112211.88	65856898	06/29/2026	NASDAQ

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
COMMON	01/23/2025	STOCK OPTION EXERCISE	ISSUER			22268	06/29/2026	CASH UPON EXERCISE

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Name and Address of Seller	Title of Securities Sold	Date of Sale	Amount of Securities Sold	Gross Proceeds
HAROLD SHLEVIN 4960 Peachtree Industrial Blvd. Ste 240 Norcross GA 30071	Common	06/26/2026	7732	38680

144: Remarks and Signature

Remarks
Date of Notice	06/29/2026
Date of Plan Adoption or Giving of Instruction, If Relying on Rule 10b5-1	08/29/2025
ATTENTION:
The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.
Signature	Harold Shlevin
ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)